openPR Logo
Press release

Albumin (as Excipient) Market Forecast 2018-2026 Made Available By Top Research Firm

01-21-2020 01:24 PM CET | Health & Medicine

Press release from: TMR

Albumin (as Excipient) Market Forecast 2018-2026 Made

Transparency Market Research has published a latest report that talks in detail about the global albumin market. According to the research report, the global albumin market is expected to reach a valuation worth US$1200 mn by the end of 2026. To achieve this valuation, the market is expected to grow at a rate of 5% CAGR over the course of the given forecast period of 2018 to 2026.

Asia Pacific Region to Showcase Maximum Growth Potential

According to the research report, the Asia Pacific region is expected to show maximum growth potential as compared to the other regional segments of North America, Latin America, Europe, and Middle East and Africa. The growth of the Asia Pacific region is high because of the growing demand for albumin in countries such as India and China. However, the rate of adoption is slightly lower due to lack of awareness and benefits of the product and its therapeutic benefits. Precisely keeping this in mind, the government and healthcare regulatory bodies have initiated several awareness campaigns. This has been particularly helpful for the growth of the albumin market in the region. Organization such as PPTA have conducted awareness programs such as International Plasma Awareness Week to aid in boosting the awareness about donation of plasma. It also raised awareness about the different therapeutic benefits of and plasma protein therapies available in the market. This has thus helped in the overall development of the albumin market in the Asia Pacific region.

albumin industry
The biotechnology and pharmacy industry segment is expected to dominate the global albumin market in the coming years of the forecast period. The segment was initially valued at US$500 mn in the year 2017. The growing research and development activities across the industry is helping to drive the growth of the global albumin market. This coupled with the growing investments provided by both private as well as public sector is also expected to help in the growth of the global albumin market.

Drug Delivery Segment to Continue to Dominate

The drug delivery segment accounts for nearly 25% of the overall market share in 2017. This trend is projected to continue over the course of the given forecast period. The usage of human serum albumin nanoparticles as a favored drug delivery system with applications for a wide range of diseases is expected to help the growth of the global market. The ongoing collaborations and joint ventures among the leading manufacturers in the global albumin market is expected to provide significant boost to the growth of the market. For example, in May 2015, Serendex Pharmaceutical announced that the company has initiated the phase I trials of Molgradex. This drug candidate is used for treating rare pulmonary diseases. The drug uses Novozymes’ Recombumin, a recombinant human albumin for more effective delivery of the therapeutic to the lungs.

For More Details, Request A PDF Brochure Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3984

The competitive landscape of the global albumin market is a consolidated one and features only a handful of leading players. Some of the big names in the global albumin market include names such as Octapharma AG, Baxter, Grifols International SA, and CSL Behring LLC. The newer and promising entrants in the albumin market refer to the established brands that are keen on developing and manufacturing albumin as an excipient. Moreover, the leading players in the market are adopting strategies such as merger, acquisitions, and joint ventures to stay ahead of the competitive curve.

This review is based on the research report published by Transparency Market Research titled, “

Albumin (as Excipient) Market (Product – Human Serum Albumin, Recombinant Albumin; Application – Human Serum Albumin Applications ( Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, In Vitro Fertilization), Recombinant Albumin Applications, Serum Albumin Applications (Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, In Vitro Fertilization); End use – Pharmaceutical & Biotechnology Industry, Research Institutes) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026”

Market Segmentation is as follows:

Product

Human Serum Albumin
Recombinant Albumin
Application

Human Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
Recombinant Albumin Applications
Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
End use

Pharmaceutical & Biotechnology Industry
Research Institutes
Geography

North America
Latin America
Asia Pacific
Middle East and Africa
Europe

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Albumin (as Excipient) Market Forecast 2018-2026 Made Available By Top Research Firm here

News-ID: 1902794 • Views: 102

More Releases from TMR

02-11-2020 | Health & Medicine
TMR
Bone Growth Stimulators Market Is Likely To Tread Along A Healthy Growth Track O …
Bone Growth Stimulators Market: Introduction According to the report, the global bone growth stimulators market was valued at US$ 1.3 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027. Bone growth stimulation is a therapy used to aid bone healing process after a fracture or spinal fusion surgery. Rise in geriatric population globally, increase in prevalence of orthopedic diseases and rising inclination of
02-11-2020 | Health & Medicine
TMR
HIV Self-test Kits Market Report Examines Growth Overview And Predictions On Siz …
HIV Self-test Kits Market: Introduction According to the report, the global HIV self-test kits market was valued at US$ 60.3 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. HIV self-testing is a screening test, which detects the presence of HIV-1/2 antibodies. HIV self-testing is a test in which a person collects his/her own specimen and performs an HIV test in a private
02-11-2020 | Health & Medicine
TMR
Fetal Monitoring Systems Market Size Examines Growth Overview And Predictions On …
Fetal Monitoring Systems Market: Introduction Transparency Market Research has published a new report titled "Fetal Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027". According to the report, the global fetal monitoring systems market was valued at approximately US$ 2.8 Bn in 2018. It is expected to expand at a CAGR of ~3% during the forecast period from 2019 to 2027. Monitoring procedures are the basis
02-11-2020 | Health & Medicine
TMR
Orthopedic Biomaterials Market Size Is In Tremendous Growth Phase | Analysis Rep …
Orthopedic Biomaterials Market: Introduction According to the report, the global orthopedic biomaterials market was valued at US$ 11.3 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Rise in percentage of population requiring orthopedic implants, and increase in incidence rate of injuries related to accidents, sports, and adventure are anticipated to augment the global orthopedic biomaterials market from 2019 to 2027. North America

All 5 Releases


More Releases for Albumin

Global Serum Albumin Market Research Report
This report studies the global Serum Albumin market status and forecast, categorizes the global Serum Albumin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Octapharma Kedrion CSL Behring Shire (Baxter) Grifols Hualan Bio Taibang Bio RAAS Greencross Geographically, this report studies
Global Glycated Albumin Market Growth 2019-2024
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy. Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Albumin Market, Growing $10,305 Million By 2023
Albumin is globular protein found in blood plasma. Serum albumin is the most abundant plasma protein, constituting around 50% of human plasma protein. Albumin is obtained from plasma fractionation process where human serum albumin and bovine serum albumin is most widely used. Recombinant albumin is produced using recombinant techniques in rice plants, yeast species, and other cell lines. Albumin is used as blood volumizer and is employed in the treatment
Global Albumin Market $307 Million by 2021
According to a market research report Albumin Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach $307 Million in 2021, expanding at a CAGR of 2.4% from 2017 to 2021. The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market
Global Glycated Albumin Sales Market Report 2017
24 Market Reports provides a complete data analysis of Global Glycated Albumin Sales Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Glycated Albumin market is expected to reach high by the end of 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated